UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

The New England journal of medicine, 2022-05, Vol.386 (21), p.1973-1985

2022

Volltextzugriff (PDF)

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

The New England journal of medicine, 2022-05, Vol.386 (21), p.1973-1985

2022

Volltextzugriff (PDF)

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL

Blood, 2016-05, Vol.127 (20), p.2411-2415

2016

Volltextzugriff (PDF)

Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non–small-cell lung cancer

Future oncology (London, England), 2023-03, Vol.19 (8), p.549-557

2023

Volltextzugriff (PDF)

Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

Cancer medicine (Malden, MA), 2018-11, Vol.7 (11), p.5382-5393

2018

Volltextzugriff (PDF)

Abstract CT003: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment (tx) for resectable (IB-IIIA) non-small cell lung cancer (NSCLC) in the phase 3 CheckMate 816 trial

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT003-CT003

2021

Volltextzugriff (PDF)

Clinical outcomes with neoadjuvant nivolumab (N) + chemotherapy (C) vs C by definitive surgery in patients (pts) with resectable NSCLC: 3-y results from the phase 3 CheckMate 816 trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8521-8521

2023

Volltextzugriff (PDF)

Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.8503-8503

2021

Volltextzugriff (PDF)

Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

The oncologist (Dayton, Ohio), 2019-04, Vol.24 (4), p.491-497

2019

Volltextzugriff (PDF)

Efficacy/safety analysis of a phase 2 study of ruxolitinib (Rux) + regorafenib (Re) in patients (pts) with relapsed/refractory (r/r) metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.663-663

2017

Volltextzugriff (PDF)

Phase II study of ruxolitinib with regorafenib for relapsed/refractory (r/r) metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS3623-TPS3623

2015

Volltextzugriff (PDF)

Abstract CT012: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment for resectable (IB-IIIA) non-small cell lung cancer (NSCLC): Event-free survival (EFS) results from the phase 3 CheckMate 816 trial

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT012-CT012

2022

Volltextzugriff (PDF)

Improved Outcomes in Intermediate- and High-Risk Aggressive Non-Hodgkin Lymphoma after Autologous Hematopoietic Stem Cell Transplantation Substituting Intravenous for Oral Busulfan in a Busulfan, Cyclophosphamide, and Etoposide Preparative Regimen

Biology of blood and marrow transplantation, 2006-07, Vol.12 (7), p.770-777

2006

Volltextzugriff (PDF)

An unusual cause of chronic cough. Foreign body aspiration

Journal of general internal medicine : JGIM, 2006-02, Vol.21 (2), p.C1-C3

2006

Volltextzugriff (PDF)

An unusual cause of chronic cough: Foreign body aspiration

Journal of general internal medicine : JGIM, 2006-02, Vol.21 (2), p.C1-C3

2006

Volltextzugriff (PDF)

CASE REPORTS: An Unusual Cause of Chronic Cough

Journal of general internal medicine : JGIM, 2006-02, Vol.21 (2), p.196

2006

Volltextzugriff (PDF)

CASE REPORT: An Unusual Cause of Chronic Cough

Journal of general internal medicine : JGIM, 2006-02, Vol.21 (2), p.C1

2006

Volltextzugriff (PDF)

An Unusual Cause of Chronic Cough

Journal of general internal medicine : JGIM, 2006-02, Vol.21 (2), p.196-196

2006

Volltextzugriff (PDF)

An Unusual Cause of Chronic Cough

Journal of general internal medicine : JGIM, 2006-02, Vol.21 (2), p.C1-C3

2006

Volltextzugriff (PDF)

EN1-3. Neoadjuvant nivolumab + platinum-doublet chemo for resectable NSCLC : CheckMate 816 surgical outcomes

Japanese Journal of Lung Cancer, 2021-10, Vol.61 (6), p.546-546

2021

Volltextzugriff (PDF)

EN1-2. Neoadjuvant nivolumab + platinum-doublet chemotherapy for resectable NSCLC : CheckMate 816 results

Japanese Journal of Lung Cancer, 2021-10, Vol.61 (6), p.545-545

2021

Volltextzugriff (PDF)

An Unusual Cause of Chronic Cough. Foreign Body Aspiration

Journal of general internal medicine : JGIM, 2006-02, Vol.21 (2), p.196-196

2006

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

SpracheNorwegisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(20)
Japanisch
(5)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL

Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non–small-cell lung cancer

Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

Abstract CT003: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment (tx) for resectable (IB-IIIA) non-small cell lung cancer (NSCLC) in the phase 3 CheckMate 816 trial

Clinical outcomes with neoadjuvant nivolumab (N) + chemotherapy (C) vs C by definitive surgery in patients (pts) with resectable NSCLC: 3-y results from the phase 3 CheckMate 816 trial

Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC)

Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

Efficacy/safety analysis of a phase 2 study of ruxolitinib (Rux) + regorafenib (Re) in patients (pts) with relapsed/refractory (r/r) metastatic colorectal cancer (mCRC)

Phase II study of ruxolitinib with regorafenib for relapsed/refractory (r/r) metastatic colorectal cancer (mCRC)

Abstract CT012: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment for resectable (IB-IIIA) non-small cell lung cancer (NSCLC): Event-free survival (EFS) results from the phase 3 CheckMate 816 trial

Improved Outcomes in Intermediate- and High-Risk Aggressive Non-Hodgkin Lymphoma after Autologous Hematopoietic Stem Cell Transplantation Substituting Intravenous for Oral Busulfan in a Busulfan, Cyclophosphamide, and Etoposide Preparative Regimen

An unusual cause of chronic cough. Foreign body aspiration

An unusual cause of chronic cough: Foreign body aspiration

CASE REPORTS: An Unusual Cause of Chronic Cough

CASE REPORT: An Unusual Cause of Chronic Cough

An Unusual Cause of Chronic Cough

An Unusual Cause of Chronic Cough

EN1-3. Neoadjuvant nivolumab + platinum-doublet chemo for resectable NSCLC : CheckMate 816 surgical outcomes

EN1-2. Neoadjuvant nivolumab + platinum-doublet chemotherapy for resectable NSCLC : CheckMate 816 results

An Unusual Cause of Chronic Cough. Foreign Body Aspiration

Aktive Filter

Suchergebnisse filtern